EGFR and carcinoma: Additionally, in the pathway enrichment analyses of carcinoma, altered pathways related to adherens junction molecules and desmosomes, such as beta-catenin binding (GO:0008013) in GO (MF) pathways, the ErbB signaling pathway (cfa04012) and Ras-associated protein 1 (Rap1) signaling pathway (cfa04015) in KEGG pathways, were identified.